首页 | 本学科首页   官方微博 | 高级检索  
检索        


Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT
Authors:Susanne Nikolaus  Andreas Wirrwar  Christina Antke  Shahram Arkian  Nils Schramm  Hans-Wilhelm Müller  Rolf Larisch
Institution:(1) Clinic of Nuclear Medicine, Heinrich-Heine University, 40225 Düsseldorf, Germany;(2) Central Laboratory for Electronics, Research Center Jülich, 52428 Jülich, Germany
Abstract:Purpose The aim of this study was to investigate the feasibility of assessing dopamine transporter binding after treatment with methylphenidate in the rat using a recently developed high-resolution small animal single-photon emission computed tomograph (TierSPECT) and 123I]FP-CIT.Methods 123I]FP-CIT was administered intravenously 1 h after intraperitoneal injection of methylphenidate (10 mg/kg) or vehicle. Animals underwent scanning 2 h after radioligand administration. The striatum was identified by superimposition of 123I]FP-CIT scans with bone metabolism and perfusion scans obtained with 99mTc-DPD and 99mTc-tetrofosmin, respectively. As these tracers do not pass the blood–brain barrier, their distribution permits the identification of extracerebral anatomical landmarks such as the orbitae and the harderian glands. The cerebellum was identified by superimposing 123I]FP-CIT scans with images of brain perfusion obtained with 99mTc-HMPAO.Results Methylphenidate-treated animals and vehicle-treated animals yielded striatal equilibrium ratios (VPrime3) of 0.24±0.26 (mean ± SD) and 1.09±0.42, respectively (t test, two-tailed, p<0.0001). Cortical VPrime3 values amounted to 0.05±0.28 (methylphenidate) and 0.3±0.39 (saline, p=0.176). This first in vivo study of rat dopamine transporter binding after pre-treatment with methylphenidate showed a mean reduction of 78% in striatal 123I]FP-CIT accumulation.Conclusion The results can be interpreted in terms of a pharmacological blockade in the rat striatum and show that in vivo quantitation of dopamine transporter binding is feasible with 123I]FP-CIT and the TierSPECT. This may be of future relevance for in vivo investigations on rat models of attention deficit/hyperactivity disorder. Furthermore, our findings suggest that investigations in other animal models, e.g. of Parkinsonrsquos and Huntingtonrsquos disease, may be feasible using SPECT radioligands and small animal imaging systems.
Keywords:Methylphenidate  [123I]FP-CIT  Dopamine transporter  Small animal tomography  Attention deficit/hyperactivity disorder
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号